News

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...
Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...
A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...
Source Reference: Makam AN, et al "Availability of cardioprotective medications for type 2 diabetes in the Medicaid program" Ann Intern Med 2025; DOI: 10.7326/ANNALS-24-01449.